Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-03

FDA Approved: RIVAROXABAN — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved the original application for rivaroxaban from Sun Pharmaceutical Industries, confirming regulatory clearance for a generic rivaroxaban product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)